Table 3.
Relation between serum level of NGAL (ng/ml) and clinicopathological characteristic of the 120 studied cases.
| NGAL (ng/ml) (mean ± SD) | p value | ||
|---|---|---|---|
| Age | <40 | 331.5 ± 72.8 | 0.006 |
| ≥40 | 509.3 ± 408 | ||
|
| |||
| Tumor size | T0-T1 | 332.1 ± 60.6 | 0.005 |
| T2 | 325.7 ± 43.6 | ||
| T3 | 383.3 ± 62.6 | ||
| T4 | 700.8 ± 549.7 | ||
|
| |||
| Lymph node | N0 | 342.6 ± 41 | 0.03 |
| N1 | 359.4 ± 78.5 | ||
| N2 | 400.5 ± 46.4 | ||
| N3 | 687.2 ± 573.7 | ||
| Unknown (X) | 353.6 ± 0 | ||
|
| |||
| Metastasis | Yes | 990.9 ± 665.3 | 0.007 |
| No | 362.9 ± 69.7 | ||
|
| |||
| Tumor grade | G1 | 466.1 ± 62.1 | 0.23 |
| G2 | 445.1 ± 334.1 | ||
| G3 | 417.5 ± 62.0 | ||
| Unknown (X) | 720.4 ± 625.9 | ||
|
| |||
| Estrogen receptor (ER) | Positive | 530.1 ± 449.8 | 0.58 |
| Negative | 488.9 ± 397.3 | ||
| Unknown (X) | 379.9 ± 57.8 | ||
|
| |||
| Progesterone receptor (PR) | Positive | 562.4 ± 510 | 0.46 |
| Negative | 475.6 ± 355.6 | ||
| Unknown (X) | 379.6 ± 57.8 | ||
|
| |||
| HER2neu | Positive | 544.5 ± 539.8 | 0.83 |
| Negative | 507.2 ± 458.4 | ||
| Unknown (X) | 459.6 ± 283.6 | ||